Tripartite Synapse: Astrocyte Regulation of Synaptic Transmission

Neurons generate action potentials through a coordinated sequence of events: at resting potential (-70 mV), voltage-gated sodium channels open upon reaching threshold (-55 mV), causing rapid depolarization to +30 mV; subsequently, potassium channels open, leading to repolarization and hyperpolarization; the sodium-potassium pump then restores the resting potential; action potentials propagate unidirectionally along axons due to refractory periods and myelination via saltatory conduction at nodes of Ranvier, ultimately triggering neurotransmitter release at synapses.

This segment explains the calcium-dependent mechanism of neurotransmitter release. When an action potential reaches the nerve terminal, it depolarizes the presynaptic membrane, triggering voltage-gated calcium channels to open. Calcium ions flow into the nerve terminal from the extracellular fluid. The calcium influx binds to proteins that facilitate vesicle fusion with the presynaptic membrane, causing synaptic vesicles to release acetylcholine into the synaptic gap. This process involves multiple proteins including SNARE proteins (SNAP-25, synaptobrevin, syntaxin) that mediate vesicle docking and fusion. The calcium-dependent release ensures neurotransmitter release occurs precisely when needed.

When action potentials reach the presynaptic terminal (the 'tip' of the neuron), they trigger the opening of voltage-gated calcium channels. Calcium ions then invade the presynaptic terminal, causing neurotransmitter-containing vesicles to fuse with the cell membrane and release their contents into the synaptic cleft. This calcium-dependent exocytosis is the mechanism by which neurons communicate with each other.

Neurotransmitter release occurs through a calcium-dependent process where action potentials trigger voltage-gated calcium channels to open, causing calcium influx that activates enzymes to separate vesicles from the cytoskeleton via synapsin; SNARE proteins (synaptobrevin/VAMP in vesicles and syntaxin/SNAP-25 in cell membrane) then form complexes to facilitate vesicle fusion with the cell membrane, with synaptotagmin acting as a calcium sensor to ensure fusion only occurs at high calcium levels, after which NSF and SNAP disassemble the SNARE complex for vesicle recycling.

The mechanism of neurotransmitter release involves: action potential arrival at the presynaptic terminal, opening of voltage-gated calcium channels, calcium influx, calcium binding to synaptotagmin protein, binding to SNARE proteins, vesicle fusion with the presynaptic membrane, and exocytosis of neurotransmitters. Synaptic potentials can be excitatory (EPSP) or inhibitory (IPSP). EPSPs depolarize the postsynaptic membrane by opening sodium channels, bringing it closer to threshold. IPSPs hyperpolarize the membrane by opening chloride or potassium channels, moving it further from threshold. The type depends on which ions flow through opened channels and the membrane's resting potential. After neurotransmitter release, neurotransmitters must be removed from the synaptic cleft through reuptake, enzymatic degradation, or diffusion to terminate their effect.

Glutamate is the primary excitatory neurotransmitter in the CNS, derived from glutamine. It acts on ionotropic (AMPA, NMDA, kainate) and metabotropic (mGluR) receptors. Termination occurs via neuronal or glial reuptake. GABA is the primary inhibitory neurotransmitter, derived from glutamate by glutamate decarboxylase. It acts primarily on GABA-A receptors (ionotropic chloride channels), causing hyperpolarization. Benzodiazepines and alcohol enhance GABA-A receptor function, producing sedative effects. The distinction between excitatory and inhibitory effects depends on the receptor type, not the neurotransmitter itself.

Glutamate is the main excitatory neurotransmitter, activating ionotropic (AMPA, NMDA, kainate) and metabotropic receptors. NMDA receptors have a magnesium block at rest, requiring depolarization for activation. Excess glutamate causes excitotoxicity via calcium influx, implicated in Alzheimer's, Parkinson's, and stroke. GABA is the main inhibitory neurotransmitter, synthesized from glutamate by GAD. GABA-A receptors are chloride channels causing hyperpolarization, while GABA-B and GABA-C are metabotropic inhibitory receptors. Glycine, used in spinal cord and brainstem, also acts as an inhibitory chloride channel.

Glutamate is the major excitatory neurotransmitter in the brain. Glutamate receptors are ion channels that allow influx of sodium and calcium when activated. GABA (gamma-aminobutyric acid) is the major inhibitory neurotransmitter. Some GABA receptors are chloride channels that open upon binding to GABA, allowing inward flow of chloride. Other GABA receptors act through G-proteins to activate potassium channels, permitting outward flow of potassium.

Glutamate is the primary excitatory neurotransmitter in the CNS, with ionotropic receptors (AMPA, NMDA, kainate) and metabotropic receptors (mGluR). GABA is the primary inhibitory neurotransmitter, with GABA-A receptors (pentameric proteins with alpha, beta, gamma subunits) and GABA-B receptors. Benzodiazepines bind to GABA-A receptors at the alpha-gamma interface, increasing chloride channel opening frequency. Barbiturates directly open chloride channels. Glycine is inhibitory in the spinal cord and brainstem. Nitric oxide is a gaseous neurotransmitter synthesized from arginine by nitric oxide synthase, involved in vasodilation and synaptic plasticity.

Glutamate is the primary excitatory neurotransmitter, used by most excitatory neurons. Its receptors (NMDA, AMPA, kainate) are ionotropic and allow sodium and calcium entry. GABA is the primary inhibitory neurotransmitter, synthesized from glutamate. GABA-A receptors are ionotropic (chloride entry), while GABA-B receptors are metabotropic (potassium modulation). Both produce hyperpolarization and inhibition. GABA antagonists block these receptors, removing inhibition and producing convulsions. GABA agonists enhance inhibition, producing calming effects and treating seizures and anxiety. The balance between excitatory and inhibitory neurotransmitters is critical for normal brain function, and disruptions in this balance produce neurological disorders.

Glial cells are classified by location into central and peripheral nervous system glia. Central nervous system glia include macroglia (astrocytes, oligodendrocytes, oligodendrocyte progenitor cells) and microglia. Astrocytes have a star shape and exist in multiple forms: fibrous astrocytes in white matter, protoplasmic astrocytes in gray matter, radial glia in embryonic development, and specialized types in retina and cerebellum. They maintain chemical conditions, regulate ion concentrations, remove neurotransmitters, store glycogen, release lactate and growth factors, and regulate synapse formation. Microglia derive from mesoderm and become activated upon CNS damage, acquiring larger size, antigen-presenting capabilities, cytokine secretion, and phagocytic abilities to modulate immune responses and clear debris. Oligodendrocyte progenitor cells (NG2 cells) give rise to oligodendrocytes throughout life.

Neuroglia are non-excitable connective tissue cells supporting the nervous system, present in 10:1 to 15:1 ratio with neurons. They are classified into Central Neuroglia (astrocytes, microglia, oligodendrocytes, ependymal cells) and Peripheral Neuroglia (Schwann cells, satellite cells). Central neuroglia include astrocytes (blood-brain barrier, chemical environment maintenance), microglia (phagocytosis), oligodendrocytes (myelin formation in CNS), and ependymal cells (CSF production). Peripheral neuroglia include Schwann cells (myelin formation and nerve regeneration in PNS) and satellite cells (support and chemical environment maintenance).

Neuroglia (glial cells) are non-excitable cells in nervous tissue that do not generate or propagate electrical signals. The term derives from 'glue' (glio), referring to their historical role in holding nervous tissue together. Despite being smaller than neurons, neuroglia are 5-25 times more numerous and can divide and multiply, unlike neurons. Neuroglia are classified into CNS (astrocytes, oligodendrocytes, ependymal cells, microglial cells) and PNS (satellite cells, Schwann cells). Astrocytes are the largest and most numerous CNS neuroglia, star-shaped with many processes. They form the blood-brain barrier by surrounding blood capillaries, selectively allowing nutrients to reach neurons while blocking harmful substances. There are two types: protoplasmic astrocytes (gray matter, short branching processes) and fibrous astrocytes (white matter, long unbranched processes). Functions include structural support through microfilaments, secreting chemicals for neuronal growth and synapse formation, maintaining ionic composition, and facilitating synaptic transmission by recycling neurotransmitters.

Neuroglia, also called glial cells or supporting cells, are the non-neuronal cells of the nervous system, being the second major cell type after neurons. They are approximately 100 times more numerous than neurons and can divide because they contain centrosomes, unlike neurons. There are five main types: astrocytes, microglia, ependymal cells, oligodendrocytes, and Schwann cells. Astrocytes are star-shaped cells and the most abundant neuroglia. They help form the blood-brain barrier along with capillary endothelium, which contains the chemoreceptor trigger zone (vomiting center). Astrocytes transport glucose and electrolytes from blood to neurons, act as primary phagocytic cells in the CNS, and help synthesize oligodendrocytes and glutamic acid.

Neuroglia are non-excitable supporting cells of the nervous system, constituting 10-15 times more cells than neurons. They are classified as CNS neuroglia (astrocytes, microglia, oligodendrocytes) and PNS neuroglia (Schwann cells, satellite cells). Astrocytes are star-shaped cells in the brain, with fibrous types in white matter helping form the blood-brain barrier through tight junctions with capillaries, and protoplasmic types in gray matter between nerve cell bodies.